Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Lung Cancer

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 95 articles: HTML format

Single Articles

March 2008
1. GOMATHINAYAGAM R , Sowmyalakshmi S, Mardhatillah F, Kumar R, et al
   Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
2. NI J , Takayama K, Ushijima R, Inoshima N, et al
   Adenovirus-mediated inhibitor kappaB gene transfer improves the chemosensitivity to anticancer drugs in human lung cancer in vitro and in vivo.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
3. TSOUTSOU PG , Froudarakis ME, Bouros D, Koukourakis MI, et al
   Hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC).
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
4. HSU W , Sheen-Chen SM, Wang JL, Huang CC, et al
   Squamous cell lung carcinoma metastatic to the breast.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
5. KIMURA H , Iizasa T, Ishikawa A, Shingyouji M, et al
   Prospective phase II study of post-surgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
6. KARAPANAGIOTOU EM , Pelekanou E, Charpidou A, Tsaganos T, et al
   Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
7. LISSONI P , Brivio F, Fumagalli L, Messina G, et al
   Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
8. KANAZAWA Y , Ueda Y, Shimasaki M, Katsuda S, et al
   Down-regulation of plakoglobin in soft tissue sarcoma is associated with a higher risk of pulmonary metastasis.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   January 2008
9. KOTTEAS E , Alamara C, Kiagia M, Pantazopoulos K, et al
   Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: a single institution experience.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
10. TISEO M , Ardizzoni A, Cafferata MA, Loprevite M, et al
    Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    
11. MALUSECKA E , Krzyzowska-Gruca S, Gawrychowski J, Fiszer-Kierzkowska A, et al
    Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    
12. HARDAVELLA G , Arkoumani E, Dalavanga Y, Galanis P, et al
    Prognostic impact of lymphangiogenesis and lymphatic invasion (CD105 expression) in small cell lung carcinoma.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    
13. ROSETTI M , Frasnelli M, Fabbri F, Arienti C, et al
    Pro-apoptotic activity of cyclopentenone in cancer cells.
    Anticancer Res. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    November 2007
14. MAEKAWA S , Iwasaki A, Shirakusa T, Enatsu S, et al
    Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
15. TIMOTHEADOU E , Skarlos DV, Samantas E, Papadopoulos S, et al
    Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
16. SATOH H , Ishikawa H, Ohara G, Kagohashi K, et al
    Long-term survivors after chemotherapy in advanced non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
17. MENCOBONI M , Bergaglio M, Serra M, Ivaldi GP, et al
    Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
18. KOSMIDIS P , Fountzilas G, Baka S, Samantas E, et al
    Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
19. USHIJIMA R , Takayama K, Izumi M, Harada T, et al
    Immunohistochemical expression of MRP2 and clinical resistance to platinum-based chemotherapy in small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
20. DAHABRE J , Vasilaki M, Stathopoulos GP, Kondaxis A, et al
    Surgical management in lung metastases from colorectal cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
21. BITTERLICH N , Schneider J
    Cut-off-independent tumour marker evaluation using ROC approximation.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    September 2007
22. KOUKOURAKIS MI , Patlakas G, Froudarakis ME, Kyrgias G, et al
    Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
23. SCORSETTI M , Navarria P, Facoetti A, Lattuada P, et al
    Effectiveness of stereotactic body radiotherapy in the treatment of inoperable early-stage lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
24. YATOMI M , Takiguchi Y, Asaka-Amano Y, Arai M, et al
    Altered gene expression by cisplatin in a human squamous cell lung carcinoma cell line.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
25. TROCH M , Streubel B, Petkov V, Turetschek K, et al
    Does MALT lymphoma of the lung require immediate treatment? An analysis of 11 untreated cases with long-term follow-up.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
26. ZHENG H , Saito H, Masuda S, Yang X, et al
    Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
27. PALWAI NR , Zang XP, Harrison RG, Pento JT, et al
    Influence of L-methioninase targeted to the urokinase receptor on the proliferation and motility of lung and prostate cancer cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    July 2007
28. OREMEK GM , Sauer-Eppel H, Bruzdziak TH
    Value of tumour and inflammatory markers in lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
29. DEMPKE W
    Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
30. WANG Q , Wang T, Wang Y, Wang W, et al
    VP-16 resistance in the NCI-H460 human lung cancer cell line is significantly associated with glucose-regulated protein78 (GRP78) induction.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
31. HARA M , Matsuzaki Y, Shimuzu T, Tomita M, et al
    Preoperative serum C-reactive protein level in non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
32. SAFRANEK J , Holubec L Jr, Topolcan O, Pesta M, et al
    Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
33. LIEBL LS , Elson F, Quaas A, Gawad KA, et al
    Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
34. SYRIGOS KN , Konstantinou M, Sepsas E, Papamichales G, et al
    Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
35. GKIOZOS I , Charpidou A, Syrigos K
    Developments in the treatment of non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
36. ZHANG X , Zhu S, Luo G, Zheng L, et al
    Expression of MMP-10 in lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
37. GIULIANI L , Favalli C, Syrjanen K, Ciotti M, et al
    Human papillomavirus infections in lung cancer. Detection of E6 and E7 transcripts and review of the literature.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
38. MIYOSHI T , Kondo K, Toba H, Yoshida M, et al
    Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
39. SAITOH-SEKIGUCHI M , Nakahara K, Kojimahara T, Ohta T, et al
    Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
40. YU NY , Conway C, Pena RL, Chen JY, et al
    STEALTH liposomal CKD-602, a topoisomerase II inhibitor, improves the therapeutic index in human tumor xenograft models.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
41. URAMOTO H , Uchiumi T, Izumi H, Kohno K, et al
    A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutation in exon 20 of EGFR.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
42. HOSAKA T , Inoue F, Ando K, Ishida H, et al
    Mutant epidermal growth factor receptor undergoes less protein degradation due to diminished binding to c-Cbl.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
43. ONO K , Suzuki T, Miki Y, Taniyama Y, et al
    Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
44. FRIEDRICH RE , Klapdor R, Bartel-Friedrich S
    Rapidly progressive and metastatic mucoepidermoid carcinoma: application of serological tumor markers.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
45. BITTERLICH N , Schneider J
    Decision guarantee in tumour marker analysis: a cut-off independent assessment.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
46. JANCARIKOVA D , Pesek M, Benesova L, Topolcan O, et al
    Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
47. SCHNEIDER J , Bitterlich N, Kotschy-Lang N, Raab W, et al
    A fuzzy-classifier using a marker panel for the detection of lung cancers in asbestosis patients.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    May 2007
48. HOTTA K , Kiura K, Tabata M, Takigawa N, et al
    Role of early serial change in serum carcinoembryonic antigen levels as a predictive marker for radiological response to gefitinib in Japanese patients with non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
49. NIEDER C , Astner ST, Grosu AL, Molls M, et al
    Evaluation of late neurologic adverse events in patients with brain metastases from non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
50. BREEN L , Heenan M, Amberger-Murphy V, Clynes M, et al
    Investigation of the role of p53 in chemotherapy resistance of lung cancer cell lines.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
51. LINGE A , Morishima N, Kasper M, Barth K, et al
    Bleomycin induces caveolin-1 and -2 expression in epithelial lung cancer A549 cells.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
52. ROY S , Kenny E, Kennedy S, Larkin A, et al
    MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
53. MURPHY L , Clynes M, Keenan J
    Proteomic analysis to dissect mitoxantrone resistance-associated proteins in a squamous lung carcinoma.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
54. STELLA M , Di Somma C, Solari N, Nozza P, et al
    Primary osteosarcoma of the spermatic cord: case report and literature review.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
55. HAUCH S , Zimmermann S, Lankiewicz S, Zieglschmid V, et al
    The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    March 2007
56. OZKAN Y , Yardim-Akaydin S, Firat H, Caliskan-Can E, et al
    Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients.
    Anticancer Res. 2007;27:1185-9.
    PubMed     Related articles    Abstract available
    
    
    
57. YOSHIDA M , Matsui Y, Ikarashi Y, Usui T, et al
    Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
    Anticancer Res. 2007;27:729-36.
    PubMed     Related articles    Abstract available
    
    
    
58. METRO G , Pino S, Pellegrini D, Sacerdoti G, et al
    Brain radiotherapy during treatment with anticonvulsant therapy as a trigger for toxic epidermal necrolysis.
    Anticancer Res. 2007;27:1167-9.
    PubMed     Related articles    Abstract available
    
    
    
59. MEYER A , Bruns F, Richter K, Grunwald V, et al
    Small cell cancer of the anal canal--case report of a rare tumor.
    Anticancer Res. 2007;27:1047-50.
    PubMed     Related articles    Abstract available
    
    
    
60. MEYER A , Behrend M
    32-year survival with metastatic adrenal cortical carcinoma--update of a case report.
    Anticancer Res. 2007;27:1045-6.
    PubMed     Related articles    Abstract available
    
    
    
61. SKALICKY SE , Ow K, Hannan M, Russell PJ, et al
    P53 expression is associated with malignant potential in xenograft tissues of a fibrosarcoma mouse model.
    Anticancer Res. 2007;27:973-8.
    PubMed     Related articles    Abstract available
    
    
    
62. POHLEN U , Rieger H, Meyer BT, Loddenkemper C, et al
    Chemoembolization of lung metastases--pharmacokinetic behaviour of carboplatin in a rat model.
    Anticancer Res. 2007;27:809-15.
    PubMed     Related articles    Abstract available
    
    
    January 2007
63. LEE I , Kalota A, Gewirtz AM, Shogen K, et al
    Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
64. EBARA T , Tanio N, Etoh T, Shichi I, et al
    Palliative re-irradiation for in-field recurrence after definitive radiotherapy in patients with primary lung cancer.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
65. PUSZTAI R , Ferreira MJ, Duarte N, Engi H, et al
    Macrocyclic lathyrane diterpenes as antitumor promoters.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
66. LAI MY , Leung HW, Yang WH, Chen WH, et al
    Up-regulation of matrix metalloproteinase family gene involvement in ursolic acid-induced human lung non-small carcinoma cell apoptosis.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    
67. ZHENG H , Tsuneyama K, Takahashi H, Miwa S, et al
    Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
    Anticancer Res. 2007;27.
    PubMed     Related articles    Abstract available
    
    
    November 2006
68. KOYAMA N , Jinn Y, Takabe K, Yoshizawa M, et al
    The characterization of gefitinib sensitivity and adverse events in patients with non-small cell lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
69. KANOH Y , Ohara T, Mashiko T, Abe T, et al
    Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
70. VASHISHTA A , Ohri SS, Proctor M, Fusek M, et al
    Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
71. CAMPS C , Sirera R, Bremnes RM, Rodenas V, et al
    Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
72. BRUECKL WM , Herbst L, Lechler A, Fuchs F, et al
    Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practice.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
73. HINO M , Kobayashi K, Yoshimura A, Takeda Y, et al
    Weekly administration of irinotecan (CPT-11) plus cisplatin for non-small cell lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
74. BATZIOS S , Michalopoulos A, Kaklamanis L, Stathopoulos J, et al
    Angiosarcoma of the heart: case report and review of the literature.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
75. OHASHI K , Kiura K, Takigawa N, Mizushima T, et al
    Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabine.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
76. LEV-ARI S , Starr A, Vexler A, Karaush V, et al
    Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
77. YOSHINAKA R , Shibata MA, Morimoto J, Tanigawa N, et al
    COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    September 2006
78. YASUDA M , Mizukami M, Hanagiri T, Shigematsu Y, et al
    Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
79. FRIESS T , Scheuer W, Hasmann M
    Erlotinib antitumor activity in non-small cell lung cancer models is independent of HER1 and HER2 overexpression.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
80. ESPOSITO V , Campioni M, De Luca A, Spugnini EP, et al
    Analysis of HtrA1 serine protease expression in human lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
81. SZELACHOWSKA J , Jelen M, Kornafel J
    Prognostic significance of intracellular laminin and Her2/neu overexpression in non-small cell lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
82. TOMITA M , Matsuzaki Y, Shimizu T, Hara M, et al
    Relationship between serum carcinoembryonic antigen level and T status in non-small cell lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
83. CHECINSKA A , Oudejans JJ, Span SW, Rodriguez JA, et al
    The expression of TUCAN, an inhibitor of apoptosis protein, in patients with advanced non-small cell lung cancer treated with chemotherapy.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
84. NAKADATE M , Yamazaki K, Konishi J, Kinoshita I, et al
    Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
85. NISHIO M , Taguchi F, Ohyanagi F, Horikike A, et al
    Gefitinib efficacy associated with multiple expression of HER family in non-small cell lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
86. OTA N , Kawakami K, Okuda T, Takehara A, et al
    Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
87. KASAHARA K , Kimura H, Shibata K, Araya T, et al
    A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
88. QU X , Yuan Y, Xu W, Chen M, et al
    Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
89. SHI W , Siemann DW
    Augmented antitumor effects of radiation therapy by 4-1BB antibody (BMS-469492) treatment.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
90. HUGHES S , Williams RD, Webb E, Houlston RS, et al
    Meta-analysis and pooled re-analysis of copy number changes in colorectal cancer detected by comparative genomic hybridization.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
91. LEE KW , Kim JH, Park JH, Kim HP, et al
    Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
92. SUENAGA M , Yamaguchi A, Soda H, Orihara K, et al
    Antiproliferative effects of gefitinib are associated with suppression of E2F-1 expression and telomerase activity.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
93. TAKASHIMA K , Fujiwara H, Inada S, Atsuji K, et al
    Tracking of green fluorescent protein (GFP)-labeled LAK cells in mice carrying B16 melanoma metastases.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
94. LANGER F , Wintzer HO, Werner M, Weber C, et al
    A case of pulmonary carcinosarcoma (squamous cell carcinoma and osteosarcoma) treated with cisplatin and doxorubicin.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    
    
95. FABI A , Nuzzo C, Vidiri A, Ciccarese M, et al
    Bone and lung metastases from intracranial meningioma.
    Anticancer Res. 2006;26.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: